|
beta-Chloroprene |
CAS 126-99-8 | ||
CH2=CClCH=CH2 |
RTECS EI9625000 | ||
Synonyms & Trade Names 2-Chloro-1,3-butadiene; Chlorobutadiene; Chloroprene |
DOT ID & Guide 1991 131P (inhibited) |
Exposure
|
NIOSH REL: Ca C 1 ppm (3.6 mg/m3) [15-minute] See Appendix A | ||
OSHA PEL†: TWA 25 ppm (90 mg/m3) [skin] | |||
IDLH Ca [300 ppm] See: 126998 | Conversion 1 ppm = 3.62 mg/m3 |
Physical Description Colorless liquid with a pungent, ether-like odor. |
|||
MW: 88.5 |
BP: 139°F |
FRZ: -153°F |
Sol: Slight |
VP: 188 mmHg |
IP: 8.79 eV |
|
Sp.Gr: 0.96 |
Fl.P: -4°F |
UEL: 11.3% |
LEL: 1.9% |
|
Class IB Flammable Liquid: Fl.P. below 73°F and BP at or above 100°F. | |||
Incompatibilities & Reactivities Peroxides & other oxidizers [Note: Polymerizes at room temperature unless inhibited with antioxidants.] |
Measurement Methods NIOSH 1002; OSHA 112 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin, respiratory system; anxiety, irritability; dermatitis; alopecia; reproductive effects; [potential occupational carcinogen] | |
Target Organs
Eyes, skin, respiratory system, reproductive system Cancer Site [lung & skin cancer] |
See also: INTRODUCTION See ICSC CARD: 0133 See MEDICAL TESTS: 0050 |